Coccidioidomycosis primary prevention

Coccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes Coccidioides immitis Coccidioides posadasii
Differentiating Coccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Coccidioidomycosis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Coccidioidomycosis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coccidioidomycosis primary prevention
CDC on Coccidioidomycosis primary prevention
Coccidioidomycosis primary prevention in the news
Blogs on Coccidioidomycosis primary prevention
Directions to Hospitals Treating Coccidioidomycosis
Risk calculators and risk factors for Coccidioidomycosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]

Overview

There are no primary preventive measures available for Coccidioidomycosis. A vaccine is in developmental stages but is not yet available for clinical use. Avoidance of geographic locations where the disease is endemic is recommended, but this is usually not applicable in practice.